Savarino V - Search Results

1

Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors.

Tolone S, Gualtieri G, Savarino E, Frazzoni M, de Bortoli N, Furnari M, Casalino G, Parisi S, Savarino V, Docimo L. Tolone S, et al. Among authors: savarino e, savarino v. World J Gastrointest Surg. 2016 Nov 27;8(11):719-728. doi: 10.4240/wjgs.v8.i11.719. World J Gastrointest Surg. 2016. PMID: 27933133 Free PMC article. Review.

2

Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Among authors: savarino v. Aliment Pharmacol Ther. 2002 Jan;16(1):35-9. doi: 10.1046/j.1365-2036.2002.01138.x. Aliment Pharmacol Ther. 2002. PMID: 11856076 Clinical Trial.

3

Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Among authors: savarino v. Aliment Pharmacol Ther. 2002 May;16(5):881-6. doi: 10.1046/j.1365-2036.2002.01248.x. Aliment Pharmacol Ther. 2002. PMID: 11966495 Clinical Trial.

4

Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Among authors: savarino v. Aliment Pharmacol Ther. 2003 Jan;17(2):235-41. doi: 10.1046/j.1365-2036.2003.01405.x. Aliment Pharmacol Ther. 2003. PMID: 12534408 Clinical Trial.

5

Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease.

Frazzoni M, De Micheli E, Savarino V. Frazzoni M, et al. Among authors: savarino v. Aliment Pharmacol Ther. 2003 Dec;18(11-12):1091-8. doi: 10.1046/j.1365-2036.2003.01768.x. Aliment Pharmacol Ther. 2003. PMID: 14653828

6

Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.

Frazzoni M, De Micheli E, Zentilin P, Savarino V. Frazzoni M, et al. Among authors: savarino v. Aliment Pharmacol Ther. 2004 Jul 1;20(1):81-8. doi: 10.1111/j.1365-2036.2004.01998.x. Aliment Pharmacol Ther. 2004. PMID: 15225174 Clinical Trial.

7

Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review.

Zentilin P, Dulbecco P, Savarino E, Giannini E, Savarino V. Zentilin P, et al. Among authors: savarino e, savarino v. Dig Liver Dis. 2004 Sep;36(9):565-9. doi: 10.1016/j.dld.2004.03.019. Dig Liver Dis. 2004. PMID: 15460839 Review.

8

Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor.

Zentilin P, Accornero L, Dulbecco P, Savarino E, Savarino V. Zentilin P, et al. Among authors: savarino e, savarino v. Dig Liver Dis. 2005 Jun;37(6):454-7. doi: 10.1016/j.dld.2004.06.020. Dig Liver Dis. 2005. PMID: 15893286

9

Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?

Frazzoni M, Manno M, De Micheli E, Savarino V. Frazzoni M, et al. Among authors: savarino v. Dig Liver Dis. 2006 Sep;38(9):643-8. doi: 10.1016/j.dld.2006.02.020. Epub 2006 Apr 14. Dig Liver Dis. 2006. PMID: 16627016

10

Proton pump inhibitor failure: why does it occur and how can it be managed?

Savarino V, Savarino E, Dulbecco P. Savarino V, et al. Among authors: savarino e. Digestion. 2006;73(4):215-7. doi: 10.1159/000094788. Epub 2006 Jul 27. Digestion. 2006. PMID: 16883072 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters